Cost-effectiveness of nonavalent HPV vaccination in the Netherlands.

Palmer C, Dolk C, Sabale U, Wang W, Saxena K

Open source

DOI
10.1080/14760584.2024.2322543
Published
2024 Jan-Dec
Container
Expert review of vaccines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14760584.2024.2322543,
  title = {Cost-effectiveness of nonavalent HPV vaccination in the Netherlands.},
  author = {Palmer C and Dolk C and Sabale U and Wang W and Saxena K},
  year = {2024},
  journal = {Expert review of vaccines},
  doi = {10.1080/14760584.2024.2322543},
  url = {https://doi.org/10.1080/14760584.2024.2322543}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of nonavalent HPV vaccination in the Netherlands.
AU  - Palmer C
AU  - Dolk C
AU  - Sabale U
AU  - Wang W
AU  - Saxena K
PY  - 2024
JO  - Expert review of vaccines
DO  - 10.1080/14760584.2024.2322543
UR  - https://doi.org/10.1080/14760584.2024.2322543
ER  - 

APA

C, P., C, D., U, S., W, W., & K, S. (2024). Cost-effectiveness of nonavalent HPV vaccination in the Netherlands.. Expert review of vaccines. https://doi.org/10.1080/14760584.2024.2322543

Source records